Related by context. Frequent words. (Click for all words.) 75 Carfilzomib 75 humanized monoclonal antibody 75 orally bioavailable 74 humanized anti 74 CYC# 73 IMC A# 72 anticancer compound 72 mTOR inhibitor 72 CCX# 72 angiogenesis inhibitor 72 MEK inhibitor 71 HCV protease inhibitor 71 Traficet EN 71 elotuzumab 71 selective inhibitor 71 Azedra 71 BAY #-# 70 SCH # 70 kinase inhibitor 70 drug conjugate 70 investigational compound 70 Phase III Clinical Trial 70 Ofatumumab 70 ATL# [001] 70 pertuzumab 70 anticancer agent 70 selectively inhibit 70 rNAPc2 70 tyrosine kinase inhibitor 70 Perifosine 69 Pivotal Phase III 69 deforolimus 69 Clinical Trial Results 69 Amrubicin 69 Preclinical Data 69 ALN TTR# 69 partial agonist 69 Pivotal Trial 69 potent inhibitor 69 RGB # 69 Vilazodone 69 hypoxia inducible factor 68 Small Molecule 68 Aurora kinase 68 Vascular Endothelial Growth 68 Nexavar ® 68 Drug Candidate 68 Bortezomib 68 CR# vcMMAE 68 registrational trial 68 Pivotal Phase 68 MORAb 68 KRN# 68 Sym# 68 proteasome inhibitors 68 antibody fragment 68 Icatibant 68 MGCD# [001] 68 PXD# 68 investigational oral 68 sphingosine 1 67 CA4P 67 PEGylated 67 OXi# 67 GLPG# 67 talabostat 67 immunomodulator 67 Completes Enrollment 67 ZD# [001] 67 luteinizing hormone releasing 67 Irinotecan 67 ANG# 67 novel anticancer 67 LY# [002] 67 FDA Accepts 67 Panitumumab 67 atacicept 67 Elesclomol 67 epothilone 67 MNTX 67 human monoclonal antibody 67 Cethromycin 67 small molecule inhibitor 67 Atiprimod 67 AP# [003] 67 injectable formulation 67 Onalta 67 induces apoptosis 67 Monoclonal Antibody 67 HDAC inhibitor 67 Patient Enrollment 66 R sorafenib tablets 66 Initiates Phase 66 antisense drug 66 pseudobulbar affect PBA 66 Metastatic Melanoma 66 investigational compounds 66 Voreloxin 66 BAL# [001] 66 AVE# 66 GRN#L